4.7 Article

The novel dual-mechanism Kv7 potassium channel/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

The ups and downs of alkyl-carbamates in epilepsy therapy: How does cenobamate differ?

Wolfgang Loescher et al.

Summary: Alkyl-carbamates have been developed for the treatment of anxiety and epilepsy since 1955, with varying levels of success. These drugs share the ability to enhance inhibitory neurotransmission through modulation of the GABA(A) receptor, but also have different mechanisms of action and adverse events. Cenobamate stands out for its unique efficacy in treating seizures, but is also associated with serious rash and low tolerability at higher doses, suggesting the need for further safety studies and clinical experience.

EPILEPSIA (2021)

Review Pharmacology & Pharmacy

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options

Wolfgang Loescher et al.

PHARMACOLOGICAL REVIEWS (2020)

Review Pharmacology & Pharmacy

TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward

Tomas R. Guilarte

PHARMACOLOGY & THERAPEUTICS (2019)

Article Chemistry, Medicinal

An Investigation into Retigabine (Ezogabine) Associated Dyspigmentation in Rat Eyes by MALDI Imaging Mass Spectrometry

M. Reid Groseclose et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2019)

Article Medicine, General & Internal

Epilepsy

Orrin Devinsky et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Review Clinical Neurology

Progesterone, 5a-dihydropogesterone and allopregnanolone's effects on seizures: A review of animal and clinical studies

Yinhao Violet Wu et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)

Review Pharmacology & Pharmacy

KCNQ-Encoded Potassium Channels as Therapeutic Targets

Vincenzo Barrese et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)

Review Biochemistry & Molecular Biology

Modulation of Kv7 channels and excitability in the brain

Derek L. Greene et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2017)

Article Biochemistry & Molecular Biology

Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs

Wolfgang Loscher

NEUROCHEMICAL RESEARCH (2017)

Article Biochemistry & Molecular Biology

The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP)

John H. Kehne et al.

NEUROCHEMICAL RESEARCH (2017)

Review Clinical Neurology

Epilepsy-associated genes

Jie Wang et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)

Editorial Material Oncology

Targeting Kv7 channels in pain pathways

Ivan Rivera-Arconada et al.

ONCOTARGET (2017)

Article Biochemistry & Molecular Biology

Translocator Protein 18 kDa (TSPO): An Old Protein with New Functions?

Fei Li et al.

BIOCHEMISTRY (2016)

Review Clinical Neurology

Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond

Wolfgang Loescher et al.

CNS DRUGS (2016)

Article Medicine, Research & Experimental

Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet

Michael A. Rogawski et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Article Pharmacology & Pharmacy

Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators

Manoj Kumar et al.

MOLECULAR PHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection

Eleonora Da Pozzo et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2015)

Review Biochemistry & Molecular Biology

Translating dosages from animal models to human clinical trials-revisiting body surface area scaling

Otis L. Blanchard et al.

FASEB JOURNAL (2015)

Review Chemistry, Medicinal

The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders

Vladimir M. Milenkovic et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2015)

Review Neurosciences

Pathway-driven discovery of epilepsy genes

Jeffrey Noebels

NATURE NEUROSCIENCE (2015)

Article Behavioral Sciences

Translocator protein mediates the anxiolytic and antidepressant effects of midazolam

Zhi-Kun Qiu et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)

Review Neurosciences

The role of allopregnanolone in depression and anxiety

Cornelius Schuele et al.

PROGRESS IN NEUROBIOLOGY (2014)

Article Pharmacology & Pharmacy

The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential

A. Boehlen et al.

BRITISH JOURNAL OF PHARMACOLOGY (2013)

Article Clinical Neurology

Neuroactive steroids for the treatment of status epilepticus

Michael A. Rogawski et al.

EPILEPSIA (2013)

Article Pharmacology & Pharmacy

Role of neurosteroids in the anticonvulsant activity of midazolam

Ashish Dhir et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

Correction Clinical Neurology

Adverse effects of antiepileptic drugs (vol 11, pg 792, 2012)

P. Perucca et al.

LANCET NEUROLOGY (2012)

Review Clinical Neurology

Adverse effects of antiepileptic drugs

Piero Perucca et al.

LANCET NEUROLOGY (2012)

Article Biotechnology & Applied Microbiology

FRESH FROM THE PIPELINE Ezogabine (retigabine)

Carl E. Stafstrom et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Chemistry, Medicinal

N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy

George Amato et al.

ACS MEDICINAL CHEMISTRY LETTERS (2011)

Article Endocrinology & Metabolism

Role of Anticonvulsant and Antiepileptogenic Neurosteroids in the Pathophysiology and Treatment of Epilepsy

Doodipala Samba Reddy

Frontiers in Endocrinology (2011)

Article Obstetrics & Gynecology

Steroid profiling in preeclamptic women: evidence for aromatase deficiency

Alexandre Hertig et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)

Review Biotechnology & Applied Microbiology

Key factors in the discovery and development of new antiepileptic drugs

Meir Bialer et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Review Biotechnology & Applied Microbiology

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

Rainer Rupprecht et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Review Pharmacology & Pharmacy

Neural KCNQ (Kv7) channels

David A. Brown et al.

BRITISH JOURNAL OF PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers

GM Ferron et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2002)

Review Pharmacology & Pharmacy

KCNQ potassium channels: physiology, pathophysiology, and pharmacology

J Robbins

PHARMACOLOGY & THERAPEUTICS (2001)

Review Neurosciences

Neuronal KCNQ potassium channels: Physiology and role in disease

TJ Jentsch

NATURE REVIEWS NEUROSCIENCE (2000)